Abnormal Cardiac Structure and Function in the Metabolic Syndrome: a Population-based Study

Overview

Journal Mayo Clin Proc

Specialty General Medicine

Date 2008 Dec 3

PMID 19046554

Citations 23

Authors

Bilal Aijaz

Khawaja A Ammar

Francisco Lopez-Jimenez

Margaret M Redfield

Steven J Jacobsen

Richard J Rodeheffer

Affiliations

Soon will be listed here.

Abstract

Objective: To measure the association between cardiac structure and function abnormalities and isolated metabolic syndrome (metabolic syndrome excluding established hypertension or diabetes mellitus).

Participants And Methods: We collected data prospectively on a population-based random sample of 2042 Olmsted County, Minnesota, residents aged 45 years or older who underwent echocardiography between January 1, 1997, and September 30, 2000. Metabolic syndrome was defined by National Cholesterol Education Program Adult Treatment Panel III criteria.

Results: The prevalence of isolated metabolic syndrome was 21.7% (214/984) in men and 16.7% (177/1058) in women. Left ventricular (LV) mass index was greater (91.7 vs 87.9 g/m2; P=.04) and LV diastolic dysfunction more prevalent (28.2% [50/177] vs 14.9% [81/544]; P<.001) in women with isolated metabolic syndrome than in women without metabolic syndrome; no difference was found in men. When patients with hypertension or diabetes mellitus were included in the cohort, there was a stepwise increase in LV mass index and LV diastolic dysfunction from no metabolic syndrome to isolated metabolic syndrome to metabolic syndrome in women and men.

Conclusion: Isolated metabolic syndrome, which is associated with increased LV mass index and LV diastolic dysfunction in women, identifies women with evidence of early ventricular dysfunction.

Citing Articles

The effects of long-term changes in metabolic parameters on cardiac remodeling and dysfunction.

Kanda D, Ohishi M Hypertens Res. 2023; 47(3):816-818.

PMID: 38135847 DOI: 10.1038/s41440-023-01555-w.

Associations between long-term averages of metabolic parameters in adulthood and cardiac structure and function in later life.

Wu Y, Chen C, Wei F, Liang W, Dong Y, Liu C Hypertens Res. 2023; 47(2):496-506.

PMID: 37857766 DOI: 10.1038/s41440-023-01475-9.

Positive additive interaction effects of age, sex, obesity, and metabolic syndrome on left ventricular dysfunction.

Zhou D, Ye Z, Nie Z, Chen C, Luo S, Yan M J Diabetes. 2023; 16(1):e13478.

PMID: 37743094 PMC: 10809287. DOI: 10.1111/1753-0407.13478.

Alterations in diastolic function and cardiac geometry in children: a longitudinal study across the spectrum of dialysis and transplant.

Sgambat K, Clauss S, Moudgil A Pediatr Nephrol. 2022; 38(6):1887-1896.

PMID: 36357638 DOI: 10.1007/s00467-022-05771-3.

Adipose tissue dysfunction, inflammation, and insulin resistance: alternative pathways to cardiac remodelling in schizophrenia. A multimodal, case-control study.

Osimo E, Sweeney M, de Marvao A, Berry A, Statton B, Perry B Transl Psychiatry. 2021; 11(1):614.

PMID: 34873143 PMC: 8648771. DOI: 10.1038/s41398-021-01741-9.

References

. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25):3143-421. View

De Simone G, Devereux R, Roman M, Alderman M, LARAGH J . Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension. 1994; 23(5):600-6. DOI: 10.1161/01.hyp.23.5.600. View

Stamler J, Vaccaro O, Neaton J, Wentworth D . Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993; 16(2):434-44. DOI: 10.2337/diacare.16.2.434. View

Mak K, Ma S, Heng D, Tan C, Tai E, Topol E . Impact of sex, metabolic syndrome, and diabetes mellitus on cardiovascular events. Am J Cardiol. 2007; 100(2):227-33. DOI: 10.1016/j.amjcard.2007.02.090. View

McNeill A, Rosamond W, Girman C, Golden S, Schmidt M, East H . The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005; 28(2):385-90. DOI: 10.2337/diacare.28.2.385. View

Verdecchia P, Angeli F, Borgioni C, Gattobigio R, de Simone G, Devereux R . Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. Am J Hypertens. 2003; 16(11 Pt 1):895-9. DOI: 10.1016/s0895-7061(03)01018-5. View

Erdogan D, Gullu H, Caliskan M, Ciftci O, Baycan S, Bilgi M . Fasting hypertriglyceridaemia increases carotid intima-media thickness and impairs coronary microvascular functions in non-obese middle aged women but not in men. Heart. 2006; 92(2):259-60. PMC: 1860775. DOI: 10.1136/hrt.2005.064741. View

Koren-Morag N, Goldbourt U, Tanne D . Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack: a prospective cohort study in patients with atherosclerotic cardiovascular disease. Stroke. 2005; 36(7):1366-71. DOI: 10.1161/01.STR.0000169945.75911.33. View

Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E . Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens. 2004; 22(10):1991-8. DOI: 10.1097/00004872-200410000-00023. View

10.

Saltevo J, Vanhala M, Kautiainen H, Kumpusalo E, Laakso M . Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study. Diabet Med. 2008; 25(6):747-50. DOI: 10.1111/j.1464-5491.2008.02440.x. View

11.

. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997; 157(21):2413-46. DOI: 10.1001/archinte.157.21.2413. View

12.

Galderisi M, Anderson K, Wilson P, Levy D . Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol. 1991; 68(1):85-9. DOI: 10.1016/0002-9149(91)90716-x. View

13.

Wilson P, DAgostino R, Parise H, Sullivan L, Meigs J . Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005; 112(20):3066-72. DOI: 10.1161/CIRCULATIONAHA.105.539528. View

14.

Berg A, Scherer P . Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005; 96(9):939-49. DOI: 10.1161/01.RES.0000163635.62927.34. View

15.

Redfield M, Rodeheffer R, Jacobsen S, Mahoney D, Bailey K, Burnett Jr J . Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002; 40(5):976-82. DOI: 10.1016/s0735-1097(02)02059-4. View

16.

Kahn R . Metabolic syndrome: is it a syndrome? Does it matter?. Circulation. 2007; 115(13):1806-10. DOI: 10.1161/CIRCULATIONAHA.106.658336. View

17.

Redfield M, Jacobsen S, Borlaug B, Rodeheffer R, Kass D . Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation. 2005; 112(15):2254-62. DOI: 10.1161/CIRCULATIONAHA.105.541078. View

18.

Pritchett A, Mahoney D, Jacobsen S, Rodeheffer R, Karon B, Redfield M . Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol. 2005; 45(1):87-92. DOI: 10.1016/j.jacc.2004.09.054. View

19.

Jacobsen S, Mahoney D, Redfield M, Bailey K, Burnett Jr J, Rodeheffer R . Participation bias in a population-based echocardiography study. Ann Epidemiol. 2004; 14(8):579-84. DOI: 10.1016/j.annepidem.2003.11.001. View

20.

Wilson P, Kannel W, Silbershatz H, DAgostino R . Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999; 159(10):1104-9. DOI: 10.1001/archinte.159.10.1104. View